Incidence and time trends of drug‐induced parkinsonism: A 30‐year population‐based study

Epidemiological studies of drug‐induced parkinsonism remain limited.

• Publication year

  2016

• Venue

  Movement Disorders

• Publication date

  2016-10-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mds.26839PMID 27779780PMCID 5318251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging

  2016cited by this paper
• Mortality Risk of Antipsychotic Dose and Duration in Nursing Home Residents with Chronic or Acute Indications

  2016cited by this paper
• Time Trends in the Incidence of Parkinson Disease.

  2016cited by this paper
• Neuroleptic‐induced Parkinsonism: Clinicopathological study

  2015cited by this paper
• Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.

  2015cited by this paper
• Incidence of dementia with Lewy bodies and Parkinson disease dementia.

  2013cited by this paper
• Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.

  2013cited by this paper
• Risk factors for Parkinson's disease may differ in men and women: an exploratory study.

  2013cited by this paper
• Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.

  2012cited by this paper
• Drug-Induced Parkinsonism

  2012cited by this paper
• Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.

  2012cited by this paper
• History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.

  2012cited by this paper
• Gender differences in the risk of familial parkinsonism: beyond LRRK2?

  2011cited by this paper
• Variants in estrogen‐related genes and risk of Parkinson's disease

  2011cited by this paper
• Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

  2011cited by this paper
• Drug induced parkinsonism: a common cause of parkinsonism in older people

  2009cited by this paper
• 1990 Census of Population and Housing: Summary Tape File 1B: Complete File for the U.S., Puerto Rico, and the U.S. Virgin Islands - Census Product Catalog - U.S. Census Bureau

  2008cited by this paper
• Drug-induced parkinsonism.

  2007cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

  2006cited by this paper
• What is the risk of developing parkinsonism following neuroleptic use?

  2006cited by this paper
• Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule‐associated protein tau

  2006cited by this paper
• Parkinsonism and Parkinson's disease in the elderly: A community‐based survey in Brazil (the Bambuí study)

  2006cited by this paper
• Chemical exposures and Parkinson's disease: A population‐based case–control study

  2006cited by this paper
• Atypical antipsychotics and parkinsonism.

  2005cited by this paper
• Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study.

  2005cited by this paper
• Stages in the development of Parkinson’s disease-related pathology

  2004cited by this paper
• Using antipsychotic agents in older patients.

  2004cited by this paper
• Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain

  2003cited by this paper
• Drug-Induced Parkinsonism

  2002cited by this paper
• Time trends in the incidence of parkinsonism in Olmsted County, Minnesota

  2001cited by this paper
• Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990

  1999cited by this paper
• Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics.

  1999cited by this paper
• Consensus statement on the diagnosis of multiple system atrophy

  1998cited by this paper
• Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology.

  1998cited by this paper
• Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.

  1997cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

  1995cited by this paper
• Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models.

  1995cited by this paper
• Commission on Professional and Hospital Activities.

  1971cited by this paper
• The occurrence, distribution and physiological role of catecholamines in the nervous system.

  1959influential reference
• [Extrapyramidal and diencephalic syndrome in the course of largactil and serpasil treatments].

  1954cited by this paper

• Comparative Analysis of the Incidence, Prevalence, and Survival of 8 Types of Parkinsonism in a Population-Based Study with 367 Million Person Years of Observation over 21 Years.

  2025cites this paper
• Global, Regional, and National burden of Parkinson's disease from 1990-2023: An Analysis of Trends, Inequalities, and Future Projections

  2025cites this paper
• Exploring cognitive and emotional symptoms associated with hippocampal subfield atrophy in drug-induced Parkinsonism

  2025cites this paper
• Incidence，clinical characteristics and related drugs analyzing of drug-induced movement disorders in 102914 inpatients:A retrospective real-world study.

  2025cites this paper
• Mild motor signs and depression: more than just medication side effects?

  2025cites this paper
• Association Between β‐Adrenoreceptor Agonists and Antagonists and Parkinson's Disease: Systematic Review and Meta‐Analysis

  2025cites this paper
• Drug-Induced Parkinsonism: A Structured, Mechanism-Informed Approach to Identification and Management

  2025cites this paper
• A Retrospective Study on Drug Induced Complications Among Different Age Groups

  2025influential citation
• Unmasking the hidden culprit: neurosyphilis mimicking parkinsonism in a middle-aged male

  2025cites this paper
• Abnormal Movements and Movement Disorder Urgencies.

  2025cites this paper
• Evaluation and Management of Tremor.

  2024cites this paper
• “It’s a Psychiatric Patient”: Misdiagnosing of Somatic Symptoms in Patients with Mental Disorders Due to Stigma and Inadequate Diagnostic Treatment

  2024cites this paper
• Subcortical structure alteration in patients with drug-induced parkinsonism: Evidence from neuroimaging

  2024cites this paper
• Rare but relevant: Methamphetamine and Parkinson's disease.

  2024cites this paper
• Drug-induced parkinsonism: diagnosis and treatment

  2024influential citation
• Levetiracetam-Induced Parkinsonism: A Short Case Series

  2024cites this paper
• Secular trends of incidence and prevalence of parkinsonism and subtypes: A cohort study in the United Kingdom

  2024cites this paper
• Early Onset Parkinsonism: Differential diagnosis and what not to miss.

  2024cites this paper
• Alpha Synuclein Toxicity and Non-Motor Parkinson’s

  2024cites this paper
• Identifying and Managing Drug Induced Parkinsonism: The Role of Neuroscience Nurses

  2024cites this paper
• Clinical presentations and diagnostic application of proposed biomarkers in psychiatric‐onset prodromal dementia with Lewy bodies

  2024cites this paper
• Prevalence and causative drugs of drug-induced Parkinsonism in pediatric patients

  2023cites this paper
• Adequate diagnosis of the cause of Parkinsonism and treatment in an elderly patient with schizophrenia: A case report

  2023cites this paper
• Air Pollution and Parkinson Disease

  2023cites this paper
• Risk factors, clinical correlates, and social functions of Chinese schizophrenia patients with drug-induced parkinsonism: A cross-sectional analysis of a multicenter, observational, real-world, prospective cohort study

  2023cites this paper
• Epilepsie, rigorös-dystone Bewegungsstörung und Tremor mit Verlust der Mobilität

  2022cites this paper
• The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson’s disease

  2022cites this paper
• SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism

  2022cites this paper
• Probable progressive supranuclear palsy in a patient with chronic schizophrenia: A case report

  2022cites this paper
• Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson's Disease

  2022cites this paper
• Usefulness of 2D Video Analysis for Evaluation of Shoulder Range of Motion during Upper Limb Exercise in Patients with Psychiatric Disorders.

  2022cites this paper
• Time to onset of drug-induced parkinsonism: Analysis using a large Japanese adverse event self-reporting database.

  2022cites this paper
• Respecting the Patient’s Choice: A Case of Possible Drug-Induced Parkinsonism

  2022cites this paper
• Parkinson's disease

  2021cites this paper
• Drug-Induced Parkinsonism

  2021cites this paper
• Descriptive epidemiological study on patients with movement disorders, with emphasis on Parkinson's disease.

  2021cites this paper
• Altered Functional Connectivity of the Orbital Cortex and Striatum Associated with Catalepsy Induced by Dopamine D1 and D2 Antagonists.

  2021cites this paper
• Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson’s disease

  2021influential citation
• Early-Onset Parkinsonism and Early-Onset Parkinson’s Disease: A Population-Based Study (2010-2015)

  2021influential citation
• Modelling Parkinson’s Disease: iPSCs towards Better Understanding of Human Pathology

  2021cites this paper
• Disproportionality by sex in the prescription of drugs capable of inducing parkinsonism for the elderly: A survey using statistics of Japanese national health claims from 2014 to 2017

  2021cites this paper
• Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative Review

  2021cites this paper
• Differences in cause and 12-month follow-up outcome of parkinsonian symptoms in depressed older adults treated with antipsychotics: a case series

  2021cites this paper
• Neurological disease and behavioral changes in the human being

  2021cites this paper
• Drug-induced parkinsonism: what should a psychiatrist know?

  2021cites this paper
• Syndromes extrapyramidaux induits par les médicaments

  2021cites this paper
• Epidemiology of Parkinson’s Disease—Current Understanding of Causation and Risk Factors

  2021cites this paper
• Use of antipsychotics and long-term risk of parkinsonism

  2021cites this paper
• Decreased thalamic monoamine availability in drug-induced parkinsonism

  2021cites this paper
• Movement Disorders: Recognition, Diagnosis, and Challenges in Care Delivery Pathways Involving the Primary Care and Specialist in Community Health Setting

  2020cites this paper
• Descriptive epidemiological study on patients with movement disorders, with emphasis on Parkinson’s disease

  2020cites this paper
• Studies on the Etiology of Parkinson’s disease

  2020cites this paper
• Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease

  2020cites this paper
• Prevalence of Extrapyramidal Symptoms in In-Patients With Severe Mental Illnesses: Focus on Parkinsonism

  2020cites this paper
• Sex differences in movement disorders.

  2020cites this paper
• Trimetazidine Use and the Risk of Parkinsonism: A Nationwide Population-Based Study

  2020cites this paper
• Parkinsonism: A Rare Adverse Effect of Valproic Acid

  2020cites this paper
• Iatrogenesis and neurological manifestations in the elderly.

  2020cites this paper
• Risks of Sulpiride-Induced Parkinsonism in Peptic Ulcer and Gastroesophageal Reflux Disease Patients in Taiwan: A Nationwide Population-Based Study

  2020cites this paper
• Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults‐a propensity score matched cohort study

  2020cites this paper
• Psychostimulant use and the brain.

  2019cites this paper
• Secondary parkinsonism due to drugs, vascular lesions, tumors, trauma, and other insults.

  2019cites this paper
• Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia.

  2019cites this paper
• Prevalence and incidence of Parkinson’s disease and drug-induced parkinsonism in Korea

  2019cites this paper
• Severe parkinsonism under treatment with antipsychotic drugs

  2019cites this paper
• Trends in the Prevalence of Drug-Induced Parkinsonism in Korea

  2019cites this paper
• Recent developments in drug-induced movement disorders: a mixed picture.

  2019cites this paper
• Minimize exposure to antidopaminergic drugs whenever possible to reduce the risk of drug-induced parkinsonism and tardive dyskinesia

  2019cites this paper
• Minimize exposure to antidopaminergic drugs whenever possible to reduce the risk of drug-induced parkinsonism and tardive dyskinesia

  2019cites this paper
• [Drug-induced Parkinsonism].

  2019cites this paper
• Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia

  2019cites this paper
• Association between Trimetazidine and Parkinsonism: A Population-Based Study

  2019cites this paper
• The Dopamine Receptor Antagonism of Opipramol: Relevance to Parkinsonism?

  2019cites this paper
• Time Trends of the Incidence, Prevalence, and Mortality of Parkinsonism

  2019cites this paper
• Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.

  2019cites this paper
• Gene-Environment-Time Interactions in Neurodegenerative Diseases: Hypotheses and Research Approaches

  2018cites this paper
• Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.

  2018cites this paper
• Major or Mild Neurocognitive Disorders with Lewy Bodies

  2018cites this paper
• Diagnosis and Treatment of Primary Headache Disorders in Older Adults

  2018cites this paper
• Extrapyramidové účinky léčiv – minimum pro farmaceuty

  2018cites this paper
• EMERGING TARGETS FOR THE TREATMENT OF PARKINSON’S DISEASE- AN OVERVIEW

  2018cites this paper
• [Movement disorders: An update].

  2018cites this paper
• The Search for Environmental Causes of Parkinson’s Disease: Moving Forward

  2018cites this paper
• Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly

  2018cites this paper
• Pimavanserin: Potential Treatment For Dementia-Related Psychosis

  2018cites this paper
• Asymmetric Drug-Induced Parkinsonism and Psychopathology: A Prospective Naturalistic Study in Long-Stay Psychiatric Patients

  2018cites this paper
• Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia—Key Differences in Pathophysiology and Clinical Management

  2018cites this paper
• Charakteristika und Dynamik der stationären Behandlung von Parkinson-Patienten in Deutschland

  2018cites this paper
• Diagnostic and prognostic aspects of clinical brain dopamine transporter imaging in parkinsonism

  2018cites this paper
• Stereotactic ablative surgery does not just mean “adding another lesion”

  2017cites this paper
• A Case Report of Drug-Induced Parkinsonism Treated with Jodeung-san and Electro-acupuncture at GB34

  2017cites this paper
• Parkinson's Disease in the Very Old - Clinicopathological Observations

  2017cites this paper
• Time, Sex, Gender, History, and Dementia.

  2017cites this paper
• Drug Induced Parkinsonism: An Overview

  2017influential citation
• Response to Letter by Friedman on “Incidence and time trends of drug‐induced parkinsonism: A 30‐year population‐based study”

  2017cites this paper
• Clinicopathologic discrepancies in a population‐based incidence study of parkinsonism in olmsted county: 1991‐2010

  2017cites this paper
• Drug induced movement disorders - basics for pharmacologists

  2017cites this paper
• Drug‐induced parkinsonism

  2017cites this paper
• 83 Tardive Dyskinesia and Other Neuroleptic-Induced Syndromes

  year unknowncites this paper